1. Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities
   Alok Kafle et al, 2024, PLOS Neglected Tropical Diseases CrossRef
2. The promising role of epigenetic mediators and microRNAs in the early diagnosis of cholangiocarcinoma (Review)
   Vikrant Rai et al, 2019, World Academy of Sciences Journal CrossRef
3. Cholangiocarcinoma and liver transplantation: What we know so far?
   Ali Reza Safarpour et al, 2021, World Journal of Gastrointestinal Pathophysiology CrossRef
4. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma
   Peng Ge et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
5. A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients
   Rashid Mir et al, 2017, Leukemia & Lymphoma CrossRef
6. Contribution of RIZ1 to Regulation of Proliferation and Migration of a Liver Fluke-Related Cholangiocarcinoma Cell
   Prasong Khaenam et al, 2012, Asian Pacific Journal of Cancer Prevention CrossRef
7. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers
   Hege Marie Vedeld et al, 2020, JHEP Reports CrossRef